ampicillin and sulbactam injection powder for solution
hospira, inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 100 mg in 1 ml
ampicillin sodium and sulbactam sodium injection powder for solution
agila specialties private limited - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g in 15 g
ampicillin injection powder for solution
agila specialties private limited - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 250 mg in 1 ml
ampicillin and sulbactam sodium injection powder for solution
hospira, inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 1 g
ampicillin trihydrate capsule
golden state medical supply, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin trihydrate 250 mg
ampicillin capsule
pd-rx pharmaceuticals, inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 500 mg
ampicillin sodium injection powder for solution
app pharmaceuticals, llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g
ampicillin sodium injection powder for solution
agila specialties private limited - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd) - ampicillin 10 g in 100 ml
ampicillin capsule
avera mckennan hospital - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin 250 mg
ampicillin and sulbactam injection, powder, for solution
hikma pharmaceuticals usa inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus, escherichia coli* , klebsiella spp.* (including k. pneumoniae* ), proteus mirabilis*, bacteroides fragilis*, enterobacter spp.*, and acinetobacter calcoaceticus*. note: for information on use in pediatric patients see precautions-pediatric use and clinical studies sections. intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli, klebsiella spp. (including k. pneumoniae* ), bacteroides spp. (including b. fragilis ), and enterobacter spp.*. gynecological infections caused by beta-lactamase producing strains of escherichia coli*, and bacteroides spp.* (including b. fragilis*). *efficacy for this organism in this organ system was studied in fewer than 10 infections. while ampicillin and sul